Development of a validated RP-HPLC method for rivaroxaban quantification in pharmaceutical formulation and human blood plasma

Muhammad Jahangir; Aymen Awan; Arooj Azhar

doi:10.36721/PJPS.2023.36.5.REG.1507-1514.1

original articles

Development of a validated RP-HPLC method for rivaroxaban quantification in pharmaceutical formulation and human blood plasma

Muhammad Jahangir, Aymen Awan, Arooj Azhar

Vol. 36

Issue 5

Pages 1507-1514

Published 01 Sept 2023

DOI: 10.36721/PJPS.2023.36.5.REG.1507-1514.1

Authors Abstract Related

Authors & Affiliations

Muhammad Jahangir

Aymen Awan

Arooj Azhar

Abstract

Rivaroxaban is an anticoagulant used to prevent thromboembolism after hip or knee joint replacement surgery

Keywords

Rivaroxaban

RP-HPLC

Stability Indicating

Solid dosage form

Quantitative determination

Metrics

PlumX Metrics

original articles

Development of a validated RP-HPLC method for rivaroxaban quantification in pharmaceutical formulation and human blood plasma

Muhammad Jahangir, Aymen Awan, Arooj Azhar

Vol. 36

Issue 5

Pages 1507-1514

Published 01 Sept 2023

DOI: 10.36721/PJPS.2023.36.5.REG.1507-1514.1

Authors Abstract Related

Authors & Affiliations

Muhammad Jahangir

Aymen Awan

Arooj Azhar

Abstract

Rivaroxaban is an anticoagulant used to prevent thromboembolism after hip or knee joint replacement surgery

Keywords

Rivaroxaban

RP-HPLC

Stability Indicating

Solid dosage form

Quantitative determination

Metrics

PlumX Metrics

Development of a validated RP-HPLC method for rivaroxaban quantification in pharmaceutical formulation and human blood plasma

Authors & Affiliations

Abstract

Keywords

Metrics

Indexed & Abstracted in Leading Databases

Development of a validated RP-HPLC method for rivaroxaban quantification in pharmaceutical formulation and human blood plasma

Authors & Affiliations

Abstract

Keywords

Metrics